Non-melanoma skin cancer and HPV in persons with albinism: a call for research investment.
Persons with albinism (PWA) have excessively high risks of non-melanoma skin cancer (NMSC) if not protected from ultraviolet (UV) radiation exposures, a situation which occurs too often amongst affected persons in sub-Saharan Africa. Certain countries in Eastern and Southern Africa, where levels of UV radiation are high, also have amongst the world's highest national-level prevalence of oculocutaneous albinism. Cutaneous HPV infections, particularly β-HPVs, may be co-factors with UV in skin carcinogenesis. If this is the case, there may be a pivotal potential for NMSC risk reduction via suitable vaccine development in all at-risk populations, and with the greatest individual-level benefit in PWA. With this background, and amidst climate change-induced increases in UV exposures, the research funding and scientific community are urged to prioritise HPV research on skin carcinogenesis in PWA. In the current perspective, we summarise: (1) the putative co-role of HPV with UV in skin carcinogenesis; (2) the possible implications of a potential HPV role in NMSC carcinogenesis; (3) the risks of skin cancer in PWA in the African setting; and (4) the research needs on HPV and NMSC in PWA, including the sensitivities and ethical responsibilities of undertaking such research amongst the PWA community in the African context.
Published In
DOI
EISSN
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- Ultraviolet Rays
- Skin Neoplasms
- Papillomavirus Infections
- Oncology & Carcinogenesis
- Humans
- Albinism
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
Published In
DOI
EISSN
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- Ultraviolet Rays
- Skin Neoplasms
- Papillomavirus Infections
- Oncology & Carcinogenesis
- Humans
- Albinism
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis